There was a predominance of ductal carcinoma (86.9%) and T1–T2 tumors (60.8%), and the majority of our patients had clinical positive axillary nodes (56.5%) before treatment and had a Ki67 index between 7.4 and 19.7%. The gene discussed is MKI67; the disease is breast ductal adenocarcinoma.